Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
AMIODARONE HYDROCHLORIDE
JAMP PHARMA CORPORATION
C01BD01
AMIODARONE
200MG
TABLET
AMIODARONE HYDROCHLORIDE 200MG
ORAL
15G/50G
Prescription
Active ingredient group (AIG) number: 0118593001; AHFS:
APPROVED
2022-10-18
_JAMP Amiodarone (Amiodarone Hydrochloride Tablets) Product Monograph _ _Page 1 of 65 _ PRODUCT MONOGRAPH PR JAMP AMIODARONE Amiodarone Hydrochloride Tablets, BP Tablets, 200 mg amiodarone hydrochloride, Oral ANTIARRHYTHMIC AGENT JAMP Pharma Corporation 1310 rue Nobel Boucherville, Quebec J4B 5H3, Canada Date of Preparation: October 7, 2022 Control Number: 247020 _JAMP Amiodarone (Amiodarone Hydrochloride Tablets) Product Monograph _ _Page 2 of 65 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ............................................................3 SUMMARY PRODUCT INFORMATION............................................................................. 3 INDICATIONS AND CLINICAL USE .................................................................................. 3 CONTRAINDICATIONS ...................................................................................................... 4 WARNINGS AND PRECAUTIONS...................................................................................... 4 ADVERSE REACTIONS .................................................................................................... 19 DRUG INTERACTIONS ..................................................................................................... 25 DOSAGE AND ADMINISTRATION .................................................................................. 29 OVERDOSAGE .................................................................................................................. 32 ACTION AND CLINICAL PHARMACOLOGY ................................................................. 32 STORAGE AND STABILITY ............................................................................................. 36 SPECIAL HANDLING INSTRUCTIONS............................................................................ 36 DOSAGE FORMS, COMPOSITION AND PACKAGING ................................................... 36 PART II: SCIENTIFIC INFORMATION .......................................................................... Կարդացեք ամբողջական փաստաթուղթը